NEW YORK (MedscapeWire) Mar 04 A fresh warning against the growing "hype" of so-called "anti-aging" medicine is being sounded by a blue-ribbon panel of experts on gerontology and medicine, after one of the most comprehensive reviews to date of the scientific evidence.
Although, the panel finds "much promise" in recent basic research on aging, it says the "anti-aging" movement threatens to discredit such serious "longevity" research and discourage investment in it by philanthropists, pharmaceutical companies, and government funders. Longevity research is vital as populations age, the panel says, because at the very least it could further reduce the diseases associated with aging. "The cost savings and health-related benefits to individuals and to our society in the near future would be tremendous."…
סל התרופות כמו אקמול לחולה סרטן/ מאמר אורח מאת ד”ר אודי פרישמן
אין תגובות06/01/2020
מדי שנה רועשת וגועשת התקשורת סביב סל התרופות, מה ייכנס
תגובות רוצה להצטרף לדיון?
יש להתחבר כדי להגיב.
התחבראין תגובות עדיין. היה הראשון להגיב!